ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Older Patients Can Do Well With Stem Cell Transplants

March 30, 2007

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

November 15, 1991

NCI Will Reissue Two RFPs On Smoking TWG Will Hear Artificial Tobacco Work

September 6, 1974

NCI Announces New Summer Training Awards

November 12, 1982

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002